Position in PEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$237,520,411
+$204,479,695 QoQ
Shares Held
752,242
+607.9% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 445 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NORGES BANK holds $8,506,007,933 across 26 Medical Devices names. PEN ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
23,354,911 | $2,119,224,624 | |
| 2 | SYK |
Stryker Corp
|
4,892,615 | $1,540,390,906 | |
| 3 | MDT |
Medtronic plc
|
16,551,016 | $1,294,785,981 | |
| 4 | BSX |
Boston Scientific Corp
|
21,170,029 | $903,536,837 | |
| 5 | EW |
Edwards Lifesciences Corp
|
8,373,783 | $757,492,410 | |
| 6 | DXCM |
Dexcom Inc
|
6,868,090 | $462,565,861 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
5,823,524 | $372,763,771 | |
| 8 | STE |
STERIS plc
|
1,192,173 | $251,035,868 |
All Filings in PEN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,520,411 | 752,242 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $33,040,716 | 106,271 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $114,013,523 | 444,272 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $114,361,362 | 427,663 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $54,395,743 | 229,054 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $48,114,847 | 247,619 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $62,055,995 | 344,813 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $65,250,690 | 292,368 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $85,222,003 | 338,801 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $84,281,685 | 348,401 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $130,870,790 | 380,372 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $95,637,211 | 343,167 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $99,266,323 | 446,221 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $110,265,482 | 581,569 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $71,573,846 | 574,798 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $85,962,532 | 386,992 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $100,365,185 | 349,315 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $91,930,507 | 344,955 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $92,865,505 | 338,851 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $80,759,471 | 298,468 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $64,558,725 | 368,907 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $67,617,609 | 347,863 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $76,863,452 | 429,837 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $68,702,219 | 425,849 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||